Pharmacological characterization of the murine and human orthologs of multidrug-resistance protein in transfected human embryonic kidney cells

Molecular Pharmacology

Volumn 52, Issue 3, 1997, Pages 344-353

  Stride, Brenda D ^a   Grant, Caroline E ^a   Loe, Douglas W ^a   Hipfner, David R ^a   Cole, Susan P C ^a   Deeley, Roger G ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIMONY TARTRATE; ANTINEOPLASTIC AGENT; ARSENITE SODIUM; CISPLATIN; COLCHICINE; DAUNORUBICIN; DOXORUBICIN; EPIRUBICIN; ESTRADIOL 17 GLUCURONIDE; ETOPOSIDE; GLUTATHIONE; GLYCOPROTEIN P; LEUKOTRIENE C4; NOVOBIOCIN; TRITIUM; VINBLASTINE; VINCRISTINE;

ACTIVE TRANSPORT; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; CROSS RESISTANCE; DRUG TRANSPORT; EMBRYO; HUMAN; HUMAN CELL; MEMBRANE VESICLE; MOLECULAR CLONING; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

EID: 0030775395     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.3.344     Document Type: Article

References (37)

1. Cole, S. P. C., G. Bhardwaj, J. H Gerlach, J. E. Mackie, C. E. Grant, K. C. Almquist, A. J. Stewart, E. U. Kurz, A. M. V. Duncan, and R. G. Deeley. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science (Washington D. C.) 258:1650-1654 (1992).
2. Grant, C. E., G. Valdimarsson, D. R. Hipfner, K. C. Almquist, S. P. C. Cole, and R. G. Deeley. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res. 54:357-361 (1994).
3. Loe, D. W., R. G. Deeley, and S. P. C. Cole. Biology of the multidrug resistance-associated protein, MRP. Eur. J. Cancer 32A:945-957 (1996).
4. Gottesman, M. M., and I. Pastan. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62:385-427 (1993).
5. Endicott, J. A., and V. Ling. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem. 58:137-171 (1989).
6. Lautier, D., Y. Canitrot, R. G. Deeley, and S. P. C. Cole. Multidrug resistance mediated by the multidrug resistance protein (MRP) gene. Biochem. Pharmacol. 52:967-977 (1996).
7. Cole, S. P. C., K. E. Sparks, K. Fraser, D. W. Loe, C. E. Grant, G. M. Wilson, and R. G. Deeley. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res. 54:5902-5910 (1994).
8. Tang-Wai, D. F., S. Kajiji, F. DiCapua, D. de Graaf, I. B. Roninson, and P. Gros. Human (MDR1) and mouse (mdr1, mdr3) P-glycoproteins can be distinguished by their respective drug resistance profiles and sensitivity to modulators. Biochemistry 34:32-39 (1995).
9. Zaman, G. J. R., M. J. Flens, M. R van Leusden, M. de Haas, H. S. Mulder, J. Lankelma, H. M. Pinedo, R. J. Scheper, F. Baas, H. J. Broxterman, and P. Borst. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc. Natl. Acad. Sci. USA 91:8822-8826 (1994).
10. Breuninger, L. M., S. Paul, K. Gaughan, T. Miki, A. Chan, S. A. Aaronson, and G. D. Kruh. Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Res. 55:5342-5347 (1995).
11. Lincke, C. R., A. M. van der Bliek, G. J. Schuurhuuis, T. van der Velde-Koerts, J. J. M. Smit, and P. Borst. Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA. Cancer Res. 50:1779-1785 (1990).
12. Kirschner, L. S., L. M. Greenberger, S. I.-H. Hsu, C.-P. H. Yang, D. Cohen, R. L. Piekarz, G. Castillo, E. K.-H. Han, L. Yu, and S. B. Horwitz. Biochemical and genetic characterization of the multidrug resistance phenotype in murine macrophage-like J774.2 cells. Biochem. Pharmacol. 43: 77-87 (1992).
13. Shapiro, A. B., and V. Ling. Using purified P-glycoprotein to understand multidrug resistance. J. Bioenerg. Biomem. 27:7-13 (1995).
14. 4 export carrier in mastocytoma cells. Eur. J. Biochem. 220:599-606 (1994).
15. Loe, D. W., K. C. Almquist, S. P. C. Cole, and R. G. Deeley. ATP-dependent 17β-estradiol 17-(β-D-glucuronide) transport by multidrug resistance protein: inhibition by cholestatic steroids. J. Biol. Chem. 271:9683-9689 (1996).
16. 4 and chemotherapeutic agents in membrane vesicles: demonstration of glutathione-dependent vincristine transport. J. Biol. Chem. 271:9675-9682 (1996).
17. Muller, M., C. Meijer, G. J. R. Zaman, P. Borst, R. J. Scheper, N. H. Mulder, E. G. E. de Vries, and P. L. M. Jansen. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc. Natl. Acad. Sci. USA 91:13033-13037 (1994).
18. Jedlitschky, G., I. Leier, U. Buchholz, K. Barnouin, G. Kurz, and D. Keppler. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res. 56:988-994 (1996).
19. Shen, H., S. Paul, L. M. Breuninger, P. J. Ciaccio, N. M. Laing, M. Helt, K. D. Tew, and G. D. Kruh. Cellular and in vitro transport of glutathione conjugates by MRP. Biochemistry 35:5719-5725 (1996).
20. McGrath, T., C. Latoud, S. T. Arnold, A. R. Safa, R. L. Felsted, and M. S. Center. Mechanisms of multidrug resistance in HL60 cells: analysis of resistance associated membrane proteins and levels of mdr gene expression. Biochem. Pharmacol. 38:3611-3619 (1989).
21. Buschman, E., and P. Gros. Functional analysis of chimeric genes obtained by exchanging homologous domains of the mouse mdr1 and mdr2 genes. Mol. Cell. Biol. 11:595-603 (1991).
22. Devault, A., and P. Gros. Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities. Mol. Cell. Biol. 10:1652-1663 (1990).
23. Schinkel, A. H., J. J. M. Smit, O. van Tellingen, J. H. Beijnen, E. Wagenaar, L. van Deemter, C. A. A. M. Mol, M. A. van der Valk, E. C. Robanus-Manndag, H. P. J. te Riele, A. J. M. Berns, and P. Borst. Disruption of the mouse mdrla P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491-502 (1994).
24. Smith, A. J., J. L. P. M. Timmermans-Hereijgers, B. Roelofsen, K. W. A. Wirtz, W. J. van Blitterswijk, J. J. M. Smit, A. H. Schinkel, and P. Borst. The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice. FEBS Lett. 354:263-266 (1994).
25. Stride, B. D., G. Valdimarsson, J. H. Gerlach, G. M. Wilson, S. P. C. Cole, and R. G. Deeley. Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter. Mol. Pharmacol. 49:962-971 (1996).
26. Slapak, C. A., P. M. Fracasso, R. L. Martell, D. L. Toppmeyer, J.-M. Lecerf, and S. B. Levy. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells. Cancer Res. 54:5607-5613 (1994).
27. Lorico, A., R. G. Germino, S. Srimatkandada, C. V. Catapano, D. J. Fernandes, J. F. Germino, and A. C. Sartorelli. Increased rate of adenosine triphosphate-dependent etoposide (VP-16) efflux in a murine leukemia cell line overexpressing the multidrug resistance-associated protein (MRP) gene. Cancer Res. 55:4352-4360 (1995).
28. Wilson, G. M., and R. G. Deeley. An episomal expression vector system for monitoring sequence-specific effects on mRNA stability in human cell lines. Plasmid 33:198-207 (1995).
29. Almquist, K. C., D. W. Loe, D. R. Hipfner, J. E. Mackie, S. P. C. Cole, and R. G. Deeley. Characterization of the 190 kDa multidrug resistance protein (MRP) in drug-selected and transfected human tumor cells. Cancer Res. 55:102-110 (1995).
30. Hipfner, D. R., K. C. Almquist, B. D. Stride, R. G. Deeley, and S. P. C. Cole. Location of a protease hypersensitive region in the multidrug resistance protein (MRP) by mapping of the epitope of MRP-specific monoclonal antibody QCRL-1. Cancer Res. 56:3307-3314 (1996).
31. Cole, S. P. C. Patterns of cross-resistance in a multidrug-resistant small-cell lung carcinoma cell lines. Cancer Chemother. Pharmacol. 26:250-256 (1990).
32. Cole, S. P. C., E. R. Chanda, F. P. Dicke, J. H. Gerlach, and S. E. L. Mirski. Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II. Cancer Res. 51:3345-3352 (1991).
33. Ishikawa, T., J. J. Bao, Y. Yamane, K. Akimaru, K. Frindrich, C. D. Wright, and M. T. Kuo. Coordinated induction of MRP/GS-X pump and gamma-glutamylcysteine synthetase by heavy metals in human leukemia cells. J. Biol. Chem. 271:14981-14988 (1996).
34. Ueda, K., C. Cardarelli, M. M. Gottesman, and I. Pastan. Expression of a full-length cDNA for the human 'MDR1' gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc. Natl. Acad. Sci. USA 84:3004-3008 (1987).
35. Choi, K., C.-J. Chen, M. Kriegler, and I. B. Roninson. An altered pattern of cross-resistance in multidrug resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene. Cell 53:519-529 (1988).
36. Kajiji, S., F. Talbot, K. Grizzuti, V. Van Dyke-Phillips, M. Agresti, A. R. Safa, and P. Gros. Functional analysis of P-glycoprotein mutants identifies predicted transmembrane domain 11 as a putative drug binding site. Biochemistry 32:4185-4194 (1993).
37. Gros, P., R. Dhir, J. Croop, and F. Talbot. A single amino acid substitution strongly modulates the activity and substrate specificity of the mouse mdr1 and mdr3 drug efflux pumps. Proc. Natl. Acad. Sci. USA 88:7289-7293 (1991).